103 related articles for article (PubMed ID: 4361279)
41. Re-exposure of human lymphoblastoid cell lines to Epstein-Barr virus.
Diehl V; Wolf H; Schulte-Holthausen H; zur Hausen H
Int J Cancer; 1972 Nov; 10(3):641-51. PubMed ID: 4358042
[No Abstract] [Full Text] [Related]
42. Observations on the resistance of Fpstein-Barr virus DNA synthesis to hydroxyurea.
Mele J; Glaser R; Nonoyama M; Zimmerman J; Rapp F
Virology; 1974 Nov; 62(1):102-11. PubMed ID: 4371583
[No Abstract] [Full Text] [Related]
43. In vitro stimulation of human lymphocytes by Epstein-Barr virus.
Gerber P; Lucas SJ
Cell Immunol; 1972 Oct; 5(2):318-24. PubMed ID: 4342032
[No Abstract] [Full Text] [Related]
44. Studies on Epstein-Barr virus-related antigens. II. Biochemical properties of soluble antigen in Raji Burkitt lymphoma cells.
Matsuo T; Nishi S; Hirai H; Osato T
Int J Cancer; 1977 Mar; 19(3):364-70. PubMed ID: 14897
[TBL] [Abstract][Full Text] [Related]
45. The detection of the Epstein-Barr virus (EBV) nuclear antigen (EBNA) by anticomplement immunofluorescence. Immunoglobulin class of antibodies and role of complement.
Liabeuf A; Nelson RA; Kourilsky FM
Int J Cancer; 1975 Apr; 15(4):533-46. PubMed ID: 166939
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
Yang CS; Hewetson JF
Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
[No Abstract] [Full Text] [Related]
47. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
Callahan J; Pai S; Cotter M; Robertson ES
Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
[TBL] [Abstract][Full Text] [Related]
48. Antibody-dependent lymphocyte cytotoxicity against cells expressing Epstein-Barr virus antigens.
Pearson GR; Orr TW
J Natl Cancer Inst; 1976 Mar; 56(3):485-8. PubMed ID: 176393
[TBL] [Abstract][Full Text] [Related]
49. Recognition of the Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt lymphoma.
Gavioli R; De Campos-Lima PO; Kurilla MG; Kieff E; Klein G; Masucci MG
Proc Natl Acad Sci U S A; 1992 Jul; 89(13):5862-6. PubMed ID: 1321426
[TBL] [Abstract][Full Text] [Related]
50. Spontaneous interferon production and Epstein-Barr virus antigen expression in human lymphoid cell lines.
Adams A; Lidin B; Strander H; Cantell K
J Gen Virol; 1975 Aug; 28(2):219-23. PubMed ID: 170371
[TBL] [Abstract][Full Text] [Related]
51. Polyploidization of Epstein-Barr virus (EBV)-carrying lymphoma lines decreases the inducibility of EBV-determined early antigen following P3HR-1 virus superinfection or iododeoxyuridine treatment.
Shapiro IM; Andersson-Anvret M; Klein G
Intervirology; 1978; 10(2):94-101. PubMed ID: 209000
[TBL] [Abstract][Full Text] [Related]
52. An EBV-genome-negative cell line established from an American Burkitt lymphoma; receptor characteristics. EBV infectibility and permanent conversion into EBV-positive sublines by in vitro infection.
Klein G; Giovanella B; Westman A; Stehlin JS; Mumford D
Intervirology; 1975; 5(6):319-34. PubMed ID: 181343
[TBL] [Abstract][Full Text] [Related]
53. Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell lines.
Koizumi S; Fujiwara S; Kikuta H; Okano M; Imai S; Mizuno F; Osato T
Virology; 1986 Apr; 150(1):161-9. PubMed ID: 3006333
[TBL] [Abstract][Full Text] [Related]
54. Characteristics of cell lines derived from human leukocytes transformed by different strains of Epstein-Barr virus.
Katsuki T; Hinuma Y
Int J Cancer; 1975 Feb; 15(2):203-10. PubMed ID: 165154
[TBL] [Abstract][Full Text] [Related]
55. Immunofluorescence and anti-complement immunofluorescence absorption tests for quantitation of Epstein-Barr virus-associated antigens.
Reedman BM; Hilgers J; Hilgers F; Klein G
Int J Cancer; 1975 Apr; 15(4):566-71. PubMed ID: 166941
[TBL] [Abstract][Full Text] [Related]
56. Cognition and recognition of antigen by cell associated receptors.
Singhal SK; Wigzell H
Prog Allergy; 1971; 15():188-222. PubMed ID: 4133330
[No Abstract] [Full Text] [Related]
57. Establishment of EBNA-expressing cell lines by infection of Epstein-Barr virus (EBV)-genome-negative human lymphoma cells with different EBV strains.
Fresen KO; Hausen H
Int J Cancer; 1976 Feb; 17(2):161-6. PubMed ID: 175026
[TBL] [Abstract][Full Text] [Related]
58. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
Giunta S; Groppa G
Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
[TBL] [Abstract][Full Text] [Related]
59. Stability of specific immunoglobulin secretion by EBV-transformed lymphoblastoid cells and human-murine heterohybridomas.
Glasky MS; Reading CL
Hybridoma; 1989 Aug; 8(4):377-89. PubMed ID: 2550358
[TBL] [Abstract][Full Text] [Related]
60. Amplified direct immunofluorescence (AMDI) for detection of Epstein-Barr virus nuclear antigen.
Schmitz H; Kampa D
J Immunol Methods; 1979; 26(2):173-86. PubMed ID: 86587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
